Marco Carbone
@MCarbone_80
Followers
432
Following
2K
Statuses
303
Liver Physician and Associate Professor @unimib. Special interest in autoimmune liver diseases
Milan (IT)
Joined April 2018
📝 Hot off the press! Leveraging AI to improve diagnostic accuracy in #AIH. A huge leap in reducing diagnostic error & improving patient care #compath Collaborative work with @jnkath, led by @AlessioGerussi @unimib @EASLedu @ESOTtransplant
2
13
48
RT @AisfFegato: I temi scientifici con i Prof. @AghemoAlessio, @salvatore_petta, @lucavalenti75, @MCarbone_80, @GIUSEPPECABIBBO, Quirino La…
0
3
0
RT @AisfFegato: 🔔 La presentazione del Libro Bianco AISF si può seguire anche in diretta streaming 💻 al link #feg…
0
2
0
RT @JesusMBanales: 🙏Many thanks @pscpartners & @PSCPartnersCa 🍀😅 😊The important ones: 👉@biogipuzkoa team (@ainhoalapitz @PMRodrigues19 @a…
0
7
0
RT @PeerVoice: Available and emerging therapies for primary biliary cholangitis (PBC): Get expert insights in three new streaming episodes.…
0
2
0
RT @CiroCelsa: In press on @AGA_CGH our multicenter study 🇮🇹 🇬🇧 on 293 pts with PBC 🔥 Non-invasive tests for portal hypertension perform p…
0
11
0
RT @EASLnews: 🌷 EASL Pre-Congress Event: Consensus Conference on PBC This year, deepen your expertise with a unique pre-congress event e…
0
3
0
RT @EASLnews: 🌷We are gearing up for #EASLCongress on 7-10 May! 🔥 Early registration ends in one week! Secure your spot by 14 January 202…
0
9
0
RT @AlessioGerussi: 🌟 What’s it about? Biliary abnormalities in autoimmune hepatitis (AIH) and interface hepatitis in primary biliary chol…
0
6
0
RT @RRitunnano: Instead of listing my publications, as the year draws to an end, I want to put pressure on the commonplace assumption that…
0
1K
0
RT @CholestasisDoc: New from us: A clinical trial of vancomycin was associated with reduction in colitis activity in PSC. We also studied…
0
21
0
RT @antoniomol83: Happy to announce that my research lab is opening in 2025 at Wallenberg laboratory @uniofgothenburg thanks to the support…
0
10
0
RT @vonderleyen: Dear Mario Draghi, a year ago, I asked you to prepare a report on the future of Europe’s competitiveness. No one was be…
0
1K
0
RT @CholestasisDoc: New from us: A clinical trial of home-based exercise intervention to improve fatigue and cognitive impairment in peop…
0
24
0
RT @BastianEngel: Struggling to identify #Autoimmune #liverdisease from histology? 🤖This #machine-learning approach got you covered. ⚡️Le…
0
3
0
RT @SpringerIME: Test your Primary Biliary Cholangitis management capabilities with this interactive case study, focussing on response to f…
0
39
0
RT @SpringerIME: Kris Kowdley and David Jones discuss the evolving landscape of primary biliary cholangitis, including new and upcoming th…
0
95
0
RT @PBCFoundation: PBC Foundation and friends in Brussels. Patients rally against EU ban on autoimmune drug. #P…
0
8
0
RT @PliantRX: Today we announced positive 24-week data from our Phase 2a INTEGRIS-PSC trial in patients with primary sclerosing cholangitis…
0
2
0
RT @CholestasisDoc: New from us: A step toward homogeneity in reporting for interventional studies, and in gaining agreement between invest…
0
5
0